Skip to main content
. 2012 May 9;15(1):139–148. doi: 10.1093/ntr/nts101

Table 1.

Demographic and Smoking Characteristics

Placebo (N = 22) Varenicline (N = 25) t/U-statistic Significance (p)
Gender, male (%) 13 (59) 10 (40) a .25
Ethnicity, n (%)
    Black 12 (55) 17 (68)
    Caucasian 8 (36) 8 (32)
    Other 2 (10) a .77
Education, n (%) .98
    High school graduate or higher 14 (64) 16 (64) −0.03
Age 43 (10) 45 (12) −0.51 .62
Years smoked 26 (11) 25 (12) 0.23 .82
Cigarettes per day 18.4 (5) 20.2 (6) −1.0 .30
CO (ppm) 15.5 (7), range: 5–35 14.8 (10), range: 4–46 219 .33
COT (ng/ml) 1,930 (1,260), range: 466–5,220 1,912 (1,327), range: 404–6,756 261 .77
FTND 5.5 (1.8) 5.6 (1.6) −0.11 .91
SCL-90 42 (10) 43 (10) −0.49 .63
BDI 3.5 (3.5) 2.7 (2.5) 0.87 .39

Note. Demographic and smoking characteristics of study completers (N = 47) at intake shown as percentages or group averages (SD). minimum and maximum range values are also shown for carbon monoxide (CO) and urinary cotinine (COT) following SD values. Fisher’s exact test was used for gender and ethnicity variables, while the Mann–Whitney Rank Sum Test was used for nonnormally distributed values found for CO and urinary COT. All other variables were analyzed with the use of t tests.

SCL-90 = Symptoms Checklist-90; BDI = Beck Depression Inventory.

a

Fisher’s exact test.